NO963792D0 - Piperazinderivater, fremgangsmåter for fremstilling samt preparater inneholdende slike - Google Patents
Piperazinderivater, fremgangsmåter for fremstilling samt preparater inneholdende slikeInfo
- Publication number
- NO963792D0 NO963792D0 NO963792A NO963792A NO963792D0 NO 963792 D0 NO963792 D0 NO 963792D0 NO 963792 A NO963792 A NO 963792A NO 963792 A NO963792 A NO 963792A NO 963792 D0 NO963792 D0 NO 963792D0
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- methods
- preparations containing
- piperazine derivatives
- piperazine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR19950000399 | 1995-01-11 | ||
| KR1019950043607A KR0162710B1 (ko) | 1995-01-10 | 1995-11-24 | 신규 피페라진 유도체 및 그 제조방법 |
| PCT/KR1996/000005 WO1996021648A1 (en) | 1995-01-11 | 1996-01-10 | New piperazine derivatives and methods for the preparation thereof and compositions containing the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO963792D0 true NO963792D0 (no) | 1996-09-10 |
| NO963792L NO963792L (no) | 1996-11-11 |
| NO307459B1 NO307459B1 (no) | 2000-04-10 |
Family
ID=26630862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO963792A NO307459B1 (no) | 1995-01-11 | 1996-09-10 | Piperazinderivater, samt farmasøytiske preparater inneholdende slike |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5780472A (no) |
| EP (1) | EP0749425A1 (no) |
| JP (1) | JP2978967B2 (no) |
| CN (1) | CN1128139C (no) |
| AU (1) | AU699619B2 (no) |
| BR (1) | BR9605309A (no) |
| CA (1) | CA2184919C (no) |
| CZ (1) | CZ288002B6 (no) |
| FI (1) | FI963566A (no) |
| HU (1) | HUP9602489A3 (no) |
| NO (1) | NO307459B1 (no) |
| NZ (1) | NZ298499A (no) |
| PL (1) | PL183865B1 (no) |
| RO (1) | RO115159B1 (no) |
| SK (1) | SK282252B6 (no) |
| WO (1) | WO1996021648A1 (no) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2185984C (en) * | 1995-01-23 | 2007-12-04 | Hirokazu Annoura | Medicament for the alleviation or treatment of symptom derived from ischemic disease and compound useful therefor |
| WO1998000402A1 (en) * | 1996-06-29 | 1998-01-08 | Samjin Pharmaceutical Co., Ltd. | Piperazine derivatives and process for the preparation thereof |
| US6794392B1 (en) | 1996-09-30 | 2004-09-21 | Schering Aktiengesellschaft | Cell differentiation inducer |
| US6174905B1 (en) * | 1996-09-30 | 2001-01-16 | Mitsui Chemicals, Inc. | Cell differentiation inducer |
| KR100420616B1 (ko) * | 1996-12-26 | 2004-05-17 | 동화약품공업주식회사 | 신규테레프탈산아미드유도체 |
| US6673799B1 (en) | 1998-09-22 | 2004-01-06 | Yamanouchi Pharmaceutical Co. Ltd. | Cyanophenyl derivative |
| AU763030B2 (en) * | 1999-03-03 | 2003-07-10 | Samjin Pharmaceutical Co., Ltd. | Piperazine derivatives and process for the preparation thereof |
| EP1301484A2 (en) | 2000-07-20 | 2003-04-16 | Neurogen Corporation | Capsaicin receptor ligands |
| DE10035908A1 (de) * | 2000-07-21 | 2002-03-07 | Asta Medica Ag | Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel |
| US6432957B1 (en) * | 2001-06-29 | 2002-08-13 | Kowa Co., Ltd. | Piperazine derivative |
| DE60234453D1 (de) * | 2001-07-02 | 2009-12-31 | High Point Pharmaceuticals Llc | Substituierte piperazin- und diazepanderivate zur verwendung als histamin h3 rezeptormodulatoren |
| AP2004003008A0 (en) * | 2001-10-22 | 2004-06-30 | Pfizer Prod Inc | Piperazine derivatives with CCR1 receptor antagonist activity |
| MXPA04005790A (es) * | 2001-12-14 | 2004-09-13 | Novo Nordisk As | Compuestos y usos de los mismos para reducir la actividad de la lipasa sensible a la hormona. |
| EP2033951A3 (en) | 2002-02-01 | 2009-12-23 | Euro-Celtique S.A. | 2-Piperazine-pyridines useful for treating pain |
| CA2491079C (en) | 2002-06-28 | 2011-10-04 | Donald J. Kyle | Therapeutic piperazine derivatives useful for treating pain |
| US7262194B2 (en) | 2002-07-26 | 2007-08-28 | Euro-Celtique S.A. | Therapeutic agents useful for treating pain |
| US7157462B2 (en) | 2002-09-24 | 2007-01-02 | Euro-Celtique S.A. | Therapeutic agents useful for treating pain |
| US8013156B2 (en) * | 2003-03-19 | 2011-09-06 | Exelixis, Inc. | Tie-2 modulators and methods of use |
| EP1836179B1 (en) * | 2004-12-30 | 2015-05-06 | Janssen Pharmaceutica NV | Piperidine- and piperazine-1-carboxylic acid amide derivatives and related compounds as modulators of fatty acid amide hydrolase (faah) for the treatment of anxiety, pain and other conditions |
| US7919495B2 (en) * | 2005-02-17 | 2011-04-05 | Astellas Pharma, Inc. | Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate compound |
| WO2007005510A1 (en) | 2005-06-30 | 2007-01-11 | Janssen Pharmaceutica N.V. | N-heteroarylpiperazinyl ureas as modulators of fatty acid amide hydrolase |
| CA2618653A1 (en) | 2005-08-12 | 2007-02-22 | Takeda Pharmaceutical Company Limited | Brain/neuronal cell-protecting agent and therapeutic agent for sleep disorder |
| PT2076508E (pt) | 2006-10-18 | 2011-03-07 | Pfizer Prod Inc | Compostos de ureia de éter biarílico |
| JO2972B1 (en) | 2007-06-08 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Piperidine / piperazine derivatives |
| EP2152271B1 (en) | 2007-06-08 | 2015-10-21 | Janssen Pharmaceutica, N.V. | Piperidine/piperazine derivatives |
| EP2152270B1 (en) | 2007-06-08 | 2015-03-04 | Janssen Pharmaceutica, N.V. | Piperidine/piperazine derivatives |
| AU2008258560C1 (en) | 2007-06-08 | 2014-04-10 | Janssen Pharmaceutica N.V. | Piperidine/piperazine derivatives |
| AU2008311727A1 (en) * | 2007-10-10 | 2009-04-16 | Takeda Pharmaceutical Company Limited | Amide compound |
| ES2617619T3 (es) | 2008-06-05 | 2017-06-19 | Janssen Pharmaceutica, N.V. | Combinaciones de fármacos que comprenden un inhibidor de DGAT y un agonista de PPAR |
| WO2011060026A1 (en) | 2009-11-12 | 2011-05-19 | Jansen Pharmaceutica Nv | Piperazinecarboxamide derivative useful as a modulator of fatty acid amide hydrolase (faah) |
| UA108233C2 (uk) | 2010-05-03 | 2015-04-10 | Модулятори активності гідролази амідів жирних кислот | |
| WO2017083216A1 (en) * | 2015-11-12 | 2017-05-18 | Merck Sharp & Dohme Corp. | Cyanopyridine derivatives as liver x receptor beta agonists, compositions, and their use |
| US11970486B2 (en) * | 2016-10-24 | 2024-04-30 | Janssen Pharmaceutica Nv | Compounds and uses thereof |
| EP3700934A4 (en) | 2017-10-24 | 2021-10-27 | Yumanity Therapeutics, Inc. | COMPOUNDS AND USES OF THESE COMPOUNDS |
| JPWO2022118966A1 (no) * | 2020-12-04 | 2022-06-09 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| OA04700A (fr) * | 1973-05-15 | 1980-07-31 | Rhone Poulenc Sa | Nouveaux dérivés de la naphtyridine et leur procédé de préparation. |
| AU7580187A (en) * | 1986-06-23 | 1988-01-12 | Upjohn Company, The | Androstane-type and cortical aminoesters |
| US4960776A (en) * | 1987-01-28 | 1990-10-02 | A. H. Robins Company, Inc. | 4-aryl-N-(alkylaminoalkyl, heterocyclicamino and heterocyclicamino)alkyl)-1-piperazinecarboxamides |
| JPH02142770A (ja) * | 1988-11-25 | 1990-05-31 | Shigeki Shin | ピペラジン系誘導体 |
| JPH03141258A (ja) * | 1989-10-25 | 1991-06-17 | Kowa Co | 新規なピペラジン誘導体 |
| DE4216364A1 (de) * | 1991-12-14 | 1993-11-25 | Thomae Gmbh Dr K | Neue Pyridylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| US5196428A (en) * | 1992-04-03 | 1993-03-23 | Bristol-Myers Squibb Company | Imidazo[4,5-b]qinolinyl oxy alkyl ureas |
-
1996
- 1996-01-10 AU AU44007/96A patent/AU699619B2/en not_active Expired
- 1996-01-10 CA CA002184919A patent/CA2184919C/en not_active Expired - Lifetime
- 1996-01-10 PL PL96316613A patent/PL183865B1/pl unknown
- 1996-01-10 NZ NZ298499A patent/NZ298499A/en not_active IP Right Cessation
- 1996-01-10 JP JP8521570A patent/JP2978967B2/ja not_active Expired - Lifetime
- 1996-01-10 SK SK889-96A patent/SK282252B6/sk unknown
- 1996-01-10 EP EP96900459A patent/EP0749425A1/en not_active Withdrawn
- 1996-01-10 RO RO96-01781A patent/RO115159B1/ro unknown
- 1996-01-10 CZ CZ19962960A patent/CZ288002B6/cs not_active IP Right Cessation
- 1996-01-10 HU HU9602489A patent/HUP9602489A3/hu unknown
- 1996-01-10 US US08/676,174 patent/US5780472A/en not_active Expired - Lifetime
- 1996-01-10 WO PCT/KR1996/000005 patent/WO1996021648A1/en not_active Application Discontinuation
- 1996-01-10 BR BR9605309A patent/BR9605309A/pt unknown
- 1996-01-10 CN CN96190006A patent/CN1128139C/zh not_active Expired - Lifetime
- 1996-09-10 NO NO963792A patent/NO307459B1/no unknown
- 1996-09-10 FI FI963566A patent/FI963566A/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI963566A0 (fi) | 1996-09-10 |
| JP2978967B2 (ja) | 1999-11-15 |
| SK88996A3 (en) | 1997-05-07 |
| CZ296096A3 (en) | 1997-02-12 |
| NZ298499A (en) | 1998-01-26 |
| HUP9602489A2 (en) | 1997-08-28 |
| EP0749425A1 (en) | 1996-12-27 |
| NO307459B1 (no) | 2000-04-10 |
| AU699619B2 (en) | 1998-12-10 |
| BR9605309A (pt) | 1997-10-14 |
| HUP9602489A3 (en) | 1998-01-28 |
| NO963792L (no) | 1996-11-11 |
| CN1128139C (zh) | 2003-11-19 |
| JPH09511764A (ja) | 1997-11-25 |
| CA2184919A1 (en) | 1996-07-18 |
| CZ288002B6 (cs) | 2001-03-14 |
| HU9602489D0 (en) | 1996-11-28 |
| WO1996021648A1 (en) | 1996-07-18 |
| RO115159B1 (ro) | 1999-11-30 |
| FI963566A (fi) | 1996-09-10 |
| PL183865B1 (pl) | 2002-07-31 |
| US5780472A (en) | 1998-07-14 |
| CA2184919C (en) | 2000-03-14 |
| AU4400796A (en) | 1996-07-31 |
| CN1145620A (zh) | 1997-03-19 |
| PL316613A1 (en) | 1997-01-20 |
| SK282252B6 (sk) | 2001-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO963792L (no) | Piperazinderivater, fremgangsmåter for fremstilling samt preparater inneholdende slike | |
| NO20002835D0 (no) | 2-aryl-oksodihydropurinderivater, fremgangsmÕte for fremstilling av disse medisinske preparater inneholdende disse, og mellomprodukter derfor | |
| DK0432040T3 (da) | Heterocykliske acylaminothiazolderivater, deres fremstilling samt farmaceutiske midler indeholdende dem | |
| NO2009028I1 (no) | Kinazolin-derivater, anvendelse og fremstilling derav, samt farmasøytisk preparat | |
| DK164868C (da) | Imidazooe4,5-baaquinolin-2-on-derivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse | |
| DK0918059T3 (da) | Susbstituerede imidazolidinderivater, deres fremstilling og anvendelse samt farmaceutiske præparater indeholdende disse derivater | |
| NO944700D0 (no) | Nye tienotiazinderivater, fremgangsmåte for fremstilling derav samt farmasöytiske preparater inneholdende forbindelsene | |
| FI941137A (fi) | 2-debentsoyyli-2-asyylitaksolijohdannaisia ja menetelmiä niiden valmistamiseksi | |
| NL970020I2 (nl) | Cinolinederivaten en werkwijzen voor de bereiding daarvan. | |
| FI973278A (fi) | Uudet farnesyylitransferaasin inhibiittorit, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet | |
| NO972881D0 (no) | Piperazinderivater, legemidler som inneholder disse, anvendelse derav og fremgangsmåte for deres fremstilling | |
| PL311999A1 (en) | Piperazine derivatives, therapeutic agents containing them and method of obtaining such derivatives | |
| DK85087D0 (da) | Substituerede thienoimidazol-derivater, deres fremstilling, praeparater, indeholdende disse, samt anvendelse deraf | |
| NO932120D0 (no) | Bifenylderivater, legemidler inneholdende disse, og fremgangsmaate for deres fremstilling | |
| DK219387D0 (da) | Aminothiazol- og aminooxazolderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse | |
| NO308287B1 (no) | Substituerte 4-fenyl-6-amino-nikotinsyrederivater, legemidler inneholdende disse samt deres anvendelse | |
| KR970000228A (ko) | S-에토돌락의 경구용 제제 | |
| NO982874D0 (no) | Farmas°ytiske preparater med vitamin D-analoger | |
| IL90007A0 (en) | N-alkoxy-alkylamido derivatives,methods for the preparation thereof and cosmetic preparations containing the same | |
| DK642588D0 (da) | Indanderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme | |
| PL316032A1 (en) | Derivatives of cephalosporin, method of obtaining them and pharmaceutic preparations containing such derivatives | |
| NO931527D0 (no) | Cykliske iminoderivater, medisinpreparater inneholdende disse, og fremgangsmaate for deres fremstilling | |
| DK486789D0 (da) | Benzoxazolinonderivater, fremgangsmaader til fremstilling deraf samt farmaceutiske midler indeholdende disse | |
| NO169339C (no) | Derivater av 4-hydroksy-2h-1-benzotiopyran-2-on, samt rottegiftpreparat hvor slike derivater inngaar | |
| EE9400148A (et) | Tienotiasiini derivaadid, nende valmistamise meetod ja neid sisaldavad farmatseutilised preparaadid |